DCAG
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for DCAG, covering 2018-02-14 to 2018-02-14. Get the full timeline:
Most recent: Clinical Trial Update: Chidamide Plus DCAG for Relapsed/Refractory AML [Phase 1, Phase 2]